Chemical genetics approach to identify peptide ligands that selectively stimulate DAPK-1 kinase activity

Biochemistry

Volumn 46, Issue 10, 2007, Pages 2655-2673

  Fraser, Jennifer A ^a   Hupp, Ted R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL GENETICS; DAPK-1 KINASE; PEPTIDE LIGANDS;

LIGANDS; PEPTIDES; RNA; SUBSTRATES; TUMORS;

ENZYME KINETICS;

ADENOSINE TRIPHOSPHATE; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; LIGAND; MYOSIN LIGHT CHAIN; PROTEIN P21; PROTEIN SERINE KINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHEMICAL GENETICS; CONFORMATIONAL TRANSITION; CONSENSUS SEQUENCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME CONFORMATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; HYDROPHOBICITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; INSECTS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33947208878     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061562j     Document Type: Article

References (47)

1. Walsh, D. P., and Chang, Y. T. (2006) Chemical genetics, Chem. Rev. 106, 2476-2530.
2. Gibbs, J. B., Oliff, A., and Kohl, N. E. (1994) Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77, 175-178.
3. Ball, K. L., Lain, S., Fahraeus, R., Smythe, C., and Lane, D. P. (1997) Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1, Curr. Biol. 7, 71-80.
4. Fahraeus, R., Paramio, J. M., Ball, K. L., Lain, S., and Lane, D. P. (1996) Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/ 1NK4A. Curr. Biol. 6, 84-91.
5. Bottger, A., Bouger, V., Sparks, A., Liu, W. L., Howard, S. F., and Lane, D. P. (1997) Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr. Biol. 7, 860-869.
6. Friedler, A., Hansson. L. O., Veprintsev, D. B., Freund, S. M., Rippin, T. M., Nikolova, P. V., Proctor, M. R., Rudiger, S., and Fersht, A. R. (2002) A peptide that binds and stabilizes p53 core domain: chaperonc strategy for rescue of oncogenic mutants, Proc. Natl. Acad. Sci. U.S.A. 99, 937-942.
7. Wallace, M., Worrall, E., Pettersson, S., Hupp, T. R., and Ball, K. L. (2006) Dual-site regulation of MDM2 E3-ubiquitin ligase activity, Mol. Cell 23, 251-263.
8. Biondi, R. M., and Nebreda, A. R. (2003) Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions, Biochem. J. 372, 1-13.
9. Craig, A., Scott, M., Burch, L., Smith, G., Ball, K., and Hupp, T. (2003) Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain, EMBO Rep. 4, 787-792.
10. Bialik, S., Bresnick, A. R., and Kimchi, A. (2004) DAP-kinase-mediated morphological changes are localization dependent and involve myosin-II phosphorylation. Cell Death Differ. 11, 631-644.
11. Velentza, A. V., Schumacher, A. M., Weiss, C., Egli, M., and Watterson, D. M. (2001) A protein kinase associated with apoptosis and tumor suppression: structure, activity, and discovery of peptide substrates. J. Biol. Chem. 276, 38956-38965.
12. Tereshko, V., Teplova, M., Brunzelle, J., Watterson, D. M., and Egli, M. (2001) Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression. Nat. struct. Biol. 8, 899-907.
13. Velentza, A. V., Schumacher, A. M., and Watterson, D. M. (2002) Structure, activity, regulation, and inhibitor discovery for a protein kinase associated with apoptosis and neuronal death. Pharmacol. Ther. 93, 217-224.
14. Yamamoto, M., Hioki, T., Ishii, T., Nakajimu-Iijima, S., and Uchino, S. (2002) DAP kinase activity is critical for C(2)-ceramide-induced apoptosis in PC12 cells, Eur. J. Biochem. 269, 139-147.
15. Shamloo, M., Soriano, L., Wieloch, T., Nikolich, K., Urfer, R., and Oksenberg, D. (2005) Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia. J. Biol. Chem. 280, 42290-42299.
16. Schumacher, A. M., Velentza, A. V., and Watterson, D. M. (2002) Death-associated protein kinase as a potential therapeutic target. Expert Opin. Ther. Targets 6, 497-506.
17. Schori, H., Yoles, E., Wheeler, L. A., Raveh, T., Kimchi, A., and Schwartz, M. (2002) Immune-related mechanisms participating in resistance and susceptibility to glutamate toxicity, Eur. J. Neurosci. 16, 557-564.
18. Pelled, D., Raveh, T., Riebeling, C., Fridkin, M., Berissi, H., Futerman, A. H. and Kimchi, A. (2002) Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons, J. Biol. Chem. 277, 1957-1961.
19. Velentza, A. V., Wainwright, M. S., Zasadzki, M., Mirzoeva, S., Schumacher, A. M., Haiech, J., Focia, P. J., Egli, M., and Watterson, D. M. (2003) An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury. Bioorg. Med. Chem. Lett. 13, 3465-3470.
20. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248-254.
21. Scott, M. T., Ingram, A., and Ball, K. L. (2002) PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J. 21, 6771-6780.
22. Burch, L. R., Scott, M., Pohler, E., Meek, D., and Hupp, T. (2004) Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1. J. Mol. Biol. 337, 115-128.
23. Kuo, J. C., Lin, J. R., Staddon, J. M., Hosoya, H., and Chen, R. H. (2003) Uncoordinated regulation of stress fibers and focal adhesions by DAP kinase, J. Cell Sci. 116, 4777-4790.
24. Niiro, N., and Ikebe, M. (2001) Zipper-interacting protein kinase induces Ca(2+)-free smooth muscle contraction via myosin light chain phosphorylation, J. Biol. Chem. 276, 29567-29574.
25. Unger, T., Juven-Gershon, T., Moallem, E., Berger, M., Vogt Sionov, R., Lozano, G., Oren, M., and Haupt, Y. (1999) Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18, 1805-1814.
26. Dornan, D., and Hupp, T. R. (2001) Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300, EMBO Rep. 2, 139-144.
27. Cohen, O., Feinstein, E., and Kimchi, A. (1997) DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 16, 998-1008.
28. Shohat, G., Spivak-Kroizman, T., Cohen, O., Bialik, S., Shani, G., Berrisi, H., Eisenstein, M., and Kimchi, A. (2001) The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. J. Biol. Chem. 276, 47460-47467.
29. Llambi, F., Lourenco, F. C., Gozuacik, D., Guix, C., Pays, L., Del Rio, G., Kimchi, A., and Mehlen, P. (2005) The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase, EMBO J. 24, 1192-1201.
30. Luciani, M. G., Hutchins, J. R., Zheleva, D., and Hupp, T. R. (2000) The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A, J. Mol. Biol. 300, 503-518.
31. Fukata, Y., Amano, M., and Kaibuchi, K. (2001) Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22, 32-39.
32. Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Mutsuuru, Y., and Kaibuchi, K. (1997) Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase, Science 275, 1308-1311.
33. Tanaka, H., Yamashita, T., Asada, M., Mizutani, S., Yoshikawa, H., and Tohyama, M. (2002) Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity, J. Cell Biol. 158, 321-329.
34. Besson, A., Gurian-West, M., Schmidt, A., Hall, A., and Roberts, J. M. (2004) p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18, 862-876.
35. Murata-Hori, M., Suizu, F., Iwasaki, T., Kikuchi, A., and Hosoya, H. (1999) ZIP kinase identified as a novel myosin regulatory light chain kinase in HeLa cells, FEBS Lett. 451, 81-84.
36. Kuo, J. C., Wang, W. J., Yao, C. C., Wu, P. R., and Chen, R. H. (2006) The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway, J. Cell Biol. 172, 619-31.
37. Komatsu, S., and Ikebe, M. (2004) ZIP kinase is responsible for the phosphorylation of myosin II and necessary for cell motility in mammalian fibroblasts, J. Cell Biol. 165, 243-254.
38. Wang, W. J., Kuo, J. C., Yao, C. C., and Chen, R. H. (2002) DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals, J. Cell Biol. 159, 169-179.
39. Rossig, L., Jadidi, A. S., Urbich, C., Badorff, C., Zeiher, A. M., and Dimmeler, S. (2001) Akt-dependent phosphorylation of p21-(Cip1) regulates PCNA binding and proliferation of endothelial cells, Mol. Cell. Biol. 21, 5644-5657.
40. Murata-Hori, M., Fukuta, Y., Ueda, K., Iwasaki, T., and Hosoya, H. (2001) HeLa ZIP kinase induces diphosphorylation of myosin II regulatory light chain and reorganization of actin filaments in nonmuscle cells, Oncogene 20, 8175-8183.
41. Graves, P. R., Winkfield, K. M., and Haystead, T. A. (2005) Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation, J. Biol. Chem. 280, 9363-9374.
42. Bode, A. M., and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis, Nat. Rev. Cancer 4, 793-805.
43. Dumaz, N., Milne, D. M., and Meek, D. W. (1999) Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15, FEBS Lett. 463, 312-316.
44. Stevens, C., Smith, L., and La Thangue, N. B. (2003) Chk2 activates E2F-1 in response to DNA damage, Nat. Cell Biol. 5, 401-409.
45. Dotto, G. P. (2000) p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471, M43-M56.
46. Kriwacki, R. W., Hengst, L., Tennant, L., Reed, S. I., and Wright, P. E. (1996) Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity, Proc. Natl. Acad. Sci. U.S.A. 93, 11504-11509.
47. Esteve, V., Canela, N., Rodriguez-Vilarrupla, A., Aligue, R., Agell, N., Mingarro, I., Bachs, O., and Perez-Paya, E. (2003) The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition, ChemBioChem 4, 863-869.